MAP2K1 and neoplasm: Our method can not only uncover disease-causing genes with abnormal expression in tumor samples such as CD74, HGF, but it can also identify genes with stable expression yet crucial roles in LUSC, such as BRAF, KDM6A, MAP2K1, and TPR.